Riskpilot← Back to searchSign inGet full accessSistani medical AB
ABBankruptOrg 5566322607Hospital activities · NACE 8610Est. 20021 employees
Revenue 2020
SEK 1,7M
+2693% vs 2019
EBITDA margin
63.2%
+1728% vs 2019
Equity ratio
30.2%
Financial strength
Net profit 2020
SEK 636K
+1225% vs 2019
| Revenue | SEK 1,7M | +2693% |
| EBITDA | SEK 1,1M | +1728% |
| Net profit | SEK 636K | +1225% |
| Total assets | SEK 2,3M | +3151% |
| Equity | SEK 708K | +258% |
| Employees | 1 | — |
Legal name
Sistani medical AB
Org number
5566322607
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
10 september 2002
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant. Registrerad särskild delgivningsmottagare saknas.
Company purpose
Bolaget ska bedriva verksamhet inom hälso - och sjukvård, utveckla teknologiska innovationer och tjänster samt förvaltning av medicintekniska produkter. Bolaget kommer även äga och förvalta fast egendom, guld, silver, ädla stenar, klockor och värdepapper, samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 60 | 1 676 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −3 | −6 | −3 | 58 | 1 060 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −6 | −3 | 58 | 1 060 |
| Net financials | — | — | — | — | — |
| Profit before tax | −3 | −6 | −3 | 58 | 810 |
| Tax | −0 | −0 | −0 | −10 | −174 |
| Net profit | −3 | −6 | −3 | 48 | 636 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 183 | 188 | 183 | 72 | 2 341 |
| Equity | 182 | 176 | 173 | 198 | 708 |
| Long-term debt | 0 | 11 | 9 | 0 | 859 |
| Short-term debt | 1 | 1 | 1 | 126 | 524 |
| Total debt | 1 | 12 | 10 | 126 | 1 383 |
EBITDA margin
63.2%
This company
15.8%
Market median
+300% vs market
20162020
Equity ratio
30.2%
This company
38.2%
Market median
+21% vs market
20162020
Return on equity
89.8%
This company
18.4%
Market median
+388% vs market
20162020
Net profit margin
37.9%
This company
8.1%
Market median
+368% vs market
20162020
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20162020
Debt / equity
2.31×
This company
0.62×
Market median
-273% vs market
20162020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sistani medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Sistani | Deputy Board Member | 0 companies |
| Farshid Sistani | Deputy Board Member | 0 companies |
| Farida Sistani | Deputy Board Member | 0 companies |
| Joseph Issa | Board of Directors | 0 companies |